What is the main business of Instytut Bioinżynierii i Medycznych Technologii?

The main business activity of Instytut Bioinżynierii i Medycznych Technologii focuses on other research and experimental development on natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 18, 2006.

Where is the headquarters located?

The headquarters is located at: Księdza Muchy 2, 66-016 Czerwieńsk.

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $36,081, representing an increase of 0.0% compared to 2023.

Is the company profitable?

No, the company recorded a net loss of $198 in 2024. For comparison, in 2023 the loss was $973, meaning the company reduced its loss by 80.6%.

Which cost dominates operating expenses?

The largest operating cost category falls under employee remuneration. This category amounted to $30,169 in 2024, representing 83% of all operating expenses.

Instytut Bioinżynierii I Medycznych Technologiisp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2006-09-18

Share capital

50,000.00 PLN

Registered address

Księdza Muchy 2/3, 66-016 Czerwieńsk, Poland

Electronic delivery address

AE:PL-81857-65464-BVADA-28

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 12 days early.

202502/07/2026
202402/07/2025
202308/07/2024
202211/07/2023
202112/07/2022
202015/09/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 9.04kMedianUSD 73.59kAverageUSD 3.23m

Net profit

This companyUSD -4.77kMedianUSD 68.18AverageUSD 82.15k

Operating costs

This companyUSD 12.09kMedianUSD 76.09kAverageUSD 3.04m

Assets

This companyUSD 33.89kMedianUSD 120.07kAverageUSD 3.90m

Industry

Authorized Representatives

Roman Ciupik – Management Board Member

Tomasz Flis – President of the Management Board

Manner of representation

The company is represented by the President of the Management Board independently. If a multi-member management board is appointed, the company is represented by the President of the Management Board independently or by two members of the management board jointly.

Ownership

Owner	Shares	Share value	Stake
Lechosław Franciszek Ciupikage 77	500	$13,506.21	100%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2000-12-21 to 2025-11-12.

Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
RS2 Europesp. z o.o.	$896,438.00	rs2.eu
AWTMsp. z o.o.	$11,058.07	awtm.pl
Instytut Produktusp. z o.o.	$10,221.64	instytutproduktu.pl
Speechflowsp. z o.o.	$9,291.81	speechflow.org
AI4Isp. z o.o.	$8,770.79	ai4i.pl
EFMS.A.	$8,156.49	engineers4medicine.com
Viratech Labssp. z o.o.	$7,516.91	viratech.pl
Amatusp. z o.o.	$7,144.85	amatu.eu
Revobudsp. z o.o.	$0.17	revobuild.com
Revobuild B.V.Branch (foreign co.)	–	revobuild.com

Change history

Date	Event
2025-04-25	Business suspended
2015-10-09	PKD change (Removed: 44 codes)
2013-01-17	Address change (Wojska Polskiego 68, 69-100, Słubice → Księdza Muchy 2/3, 66-016, Czerwieńsk)
2013-01-17	Name change ("cc Lfc" → "instytut Bioinżynierii I Medycznych Technologii")
2013-01-17	PKD change (Removed: 17 codes; Added: 20 codes)

FAQ

Last updated: 2026-10-07